Aro Biotherapeutics Funding & Investors
Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.
arobiotx.comTotal Amount Raised: $166,500,000
Aro Biotherapeutics Funding Rounds
Series B
$41,500,000
Series B Investors
BVF PartnersJohnson & Johnson Innovation – JJDCHealthCapNorthpond VenturesCowenSeries B
$24,000,000
Series B Investors
CowenSeries A
$88,000,000
Series A Investors
Ridgeback Capital ManagementHealthCapIonis PharmaceuticalsBiotechnology Value FundBioMotivNorthpond VenturesJohnson & Johnson InnovationCowenSeries Unknown
$13,000,000
Series Unknown Investors
BioMotivJohnson & Johnson Innovation
Funding info provided by Diffbot.